BioTech Blogs & News
Atavistik Bio Secures $160 Million to Advance Targeted Therapies for Rare Blood Disorders
1 Jan 1970
by Mir Moomin
Read More →
Eli Lilly Targets India with Game-Changing Obesity Pill Orforglipron
13 Apr 2026
by Mir Moomin
Read More →
Jeito Capital Closes $1.2B Fund to Back Clinical-Stage Biopharma in Europe
10 Apr 2026
by Mir Moomin
Read More →
Sidewinder Therapeutics Raises $137M to Advance Next-Gen Cancer Therapies
9 Apr 2026
by Mir Moomin
Read More →
Amgen Advances Thyroid Eye Disease Treatment with Subcutaneous Tepezza
8 Apr 2026
by Mir Moomin
Read More →
Anthropic Acquires Coefficient Bio in Reported $400M Deal, Signaling Deeper Push Into AI-Driven Biotech
7 Apr 2026
by Mir Moomin
Read More →
Neurocrine’s $2.5B Move for Soleno Reflects a New Era of Biotech Expansion
6 Apr 2026
by Mir Moomin
Read More →
FDA Approves Eli Lilly’s Foundayo, Marking a New Phase for GLP-1 Weight Loss Therapies
2 Apr 2026
by Mir Moomin
Read More →
Future Biotech Expo 2026: Global Biotech Leaders to Convene in Houston This June
31 Mar 2026
by Mir Moomin
Read More →
Q&A Session with Dr. Arturo Loaiza-Bonilla, MD
27 Mar 2026
by Mir Moomin
Read More →
After 20 Years, Denali Therapeutics Advances Hunter Syndrome Treatment with FDA Approval
27 Mar 2026
by Mir Moomin
Read More →
Q&A session with Jessie Brosch Sweet
25 Mar 2026
by Mir Moomin
Read More →
Q&A session with Chikelue Oragwu, MD, MSc
23 Mar 2026
by Mir Moomin
Read More →
Johnson & Johnson Wins FDA Approval for Icotyde, A Potential Game-Changer in Psoriasis Treatment
20 Mar 2026
by Mir Moomin
Read More →
R1 Therapeutics Bets $77.5M on New Approach to Kidney Disease Treatment
18 Mar 2026
by Mir Moomin
Read More →
Enodia Therapeutics Boosts Sec61 Pipeline with Asset Acquisition from Kezar Life Sciences
16 Mar 2026
by Mir Moomin
Read More →
Q&A Session with Dr. David Barzilai, MD, PhD, MBA, MS, DipABLM, FAAD
12 Mar 2026
by Mir Moomin
Read More →
Servier to Acquire Day One Biopharmaceuticals for $2.5 Billion, Expanding Pediatric Brain Tumor Portfolio
10 Mar 2026
by Mir Moomin
Read More →
How Biotechnology Is Redefining Elite Athletic Performance
9 Mar 2026
by Mir Moomin
Read More →
Novo Nordisk Expands Manufacturing with $506M Investment in Irish Oral Wegovy Plant
5 Mar 2026
by Mir Moomin
Read More →
Roche Bets $481M on South Korea’s Growing Biohealth Ecosystem
4 Mar 2026
by Mir Moomin
Read More →
Lynk’s Next-Gen JAK1 Inhibitor Delivers Strong Phase 3 Results in Eczema
3 Mar 2026
by Mir Moomin
Read More →
Evinova Expands AI Clinical Platform Through Deals With AstraZeneca and Astellas
26 Feb 2026
by Mir Moomin
Read More →
Gilead Makes $7.8 Billion Bet on CAR-T With Arcellx Acquisition
25 Feb 2026
by Mir Moomin
Read More →
Q&A Session With Jim Wu
24 Feb 2026
by Mir Moomin
Read More →
U.S. Invests $15 Million in Manus Bio to Secure Domestic Supply of Key Flu Drug Ingredient
21 Feb 2026
by Mir Moomin
Read More →
Scribe and Eli Lilly Move Forward in In Vivo CRISPR Effort with New Milestone Achievement
19 Feb 2026
by Mir Moomin
Read More →
Beactica and KU Leuven Secure €2.5M to Advance Glioblastoma Therapy
17 Feb 2026
by Mir Moomin
Read More →
Lundbeck’s PACAP Migraine Drug Advances to Late-Stage Development After Successful Phase II Results
16 Feb 2026
by Mir Moomin
Read More →
Spanish Scientists Under Mariano Barbacid Advance Pancreatic Cancer Research With Triple-Drug Strategy
13 Feb 2026
by Mir Moomin
Read More →
ILiAD Secures $115 Million to Advance Intranasal Pertussis Vaccine Into Pivotal Stage
11 Feb 2026
by Mir Moomin
Read More →
Eli Lilly Acquires Orna Therapeutics for $2.4B, Betting on In Vivo CAR-T Revolution
10 Feb 2026
by Mir Moomin
Read More →
Eikon Therapeutics Raises $381 Million in Nasdaq IPO, Largest Biotech Listing Since 2024
6 Feb 2026
by Mir Moomin
Read More →
Optellum Selected for NHS AI-Driven Lung Cancer Diagnostic Initiative
4 Feb 2026
by Mir Moomin
Read More →
Santé Ventures has raised $330 million for its fifth investment fund, marking the largest fundraise in the firm’s history.
3 Feb 2026
by Mir Moomin
Read More →
Eli Lilly Teams Up with German Gene-Editing Startup in $1.12 Billion Deal to Target Hearing Loss
30 Jan 2026
by Mir Moomin
Read More →
Future Biotech Expo 2026 Features Global Leaders in Biotechnology and Cancer Research
30 Jan 2026
by Urwa A. Beigh
Read More →
Fortitude Biomedicines Raises $13M Seed From K2 Bio Partners, SHAC, Elikon
28 Jan 2026
by Mir Moomin
Read More →
How the Immune System Learns Restraint, and Why Biotech Is Trying to Teach It Again
27 Jan 2026
by Mir Moomin
Read More →
J. Craig Venter Launches Diploid Genomics to Advance AI-Driven Diagnostic Insights
26 Jan 2026
by Mir Moomin
Read More →
Sanofi’s Amlitelimab Shows Late-Stage Promise, Moves Closer to Eczema Approval
23 Jan 2026
by Mir Moomin
Read More →
Pfizer’s $530 Million Bet on Novavax Signals a Strategic Shift in Vaccine Development
22 Jan 2026
by Mir Moomin
Read More →
THE RISE OF PERSONALIZED MEDICINE IN BIOTECHNOLOGY
22 Jan 2026
by Faheem
Read More →
Think Bioscience Secures Oversubscribed $55M Series A for Synthetic Biology Drug Discovery Platform
21 Jan 2026
by Mir Moomin
Read More →
From Partnership to Ownership: AstraZeneca’s $630M Deal with AbelZeta
20 Jan 2026
by Mir Moomin
Read More →
The Strategic Role of Biotechnology Today in Shaping Better Lives
16 Jan 2026
by Faisal Amin Bhat
Read More →
Novo Nordisk Foundation Commits €736M to BioInnovation Institute Through 2035
16 Jan 2026
by Mir Moomin
Read More →
Caldera Therapeutics Launches with $112.5M to Advance First-in-Class IBD Bispecific Antibody
15 Jan 2026
by Mir Moomin
Read More →
Converge Bio Raises $25M to Make AI Drug Discovery Operational
14 Jan 2026
by Mir Moomin
Read More →
How Biotech Transformed Cancer Treatment
13 Jan 2026
by Mir Moomin
Read More →
Schrödinger and Eli Lilly Expand Access to AI Drug Discovery with TuneLab Integration
12 Jan 2026
by Mir Moomin
Read More →
Amgen Acquires Dark Blue Therapeutics for Up to $840M
9 Jan 2026
by Faheem
Read More →
Sanofi Enters Potential $2.56 Billion Collaboration With Earendil Labs to Advance Autoimmune Therapies
6 Jan 2026
by Mir Moomin
Read More →
Insilico Medicine and Servier Sign Potential $888M AI-Driven Cancer Drug Deal
5 Jan 2026
by Mir Moomin
Read More →
Why the Human Genome Project Still Defines Modern Biotechnology
2 Jan 2026
by Mir Moomin
Read More →
Biopharma in 2026: The Forces Reshaping Drug Discovery, Deals, and Development
1 Jan 2026
by Mir Moomin
Read More →
FDA Approves Omeros’ Yartemlea as First Targeted Therapy for TA-TMA After Stem Cell Transplant
30 Dec 2025
by Mir Moomin
Read More →
Future BioTech Expo 2026 Set to Redefine the Global Biotechnology Landscape in Houston This June
30 Dec 2025
by Urwa A. Beigh
Read More →
What Biotech Really Is, And Why Red Biotech Matters
29 Dec 2025
by Mir Moomin
Read More →
Bharat Biotech and Spain-based Biofabri Sign Tech Transfer Deal for TB Vaccine
26 Dec 2025
by Mir Moomin
Read More →
Samsung Biologics Expands U.S. Operations With $280M GSK Facility Acquisition
24 Dec 2025
by Mir Moomin
Read More →
Ipsen Expands Oncology Pipeline With $1.06 Billion Simcere ADC Licensing Deal
23 Dec 2025
by Mir Moomin
Read More →
How AI Is Redefining Red Biotechnology: A New Era of Speed, Precision & Discovery
22 Dec 2025
by Mir Moomin
Read More →
Moon Surgical Advances Robotic Surgery with AI-Powered Maestro Platform
19 Dec 2025
by Mir Moomin
Read More →
Kane Biotech Wound Gel's Game-Changing Healing Breakthrough
18 Dec 2025
by Mir Moomin
Read More →
Texas Bets Big on Brain Health: What $3 Billion in Dementia Funding Means for Research and Biotech
17 Dec 2025
by Mir Moomin
Read More →
Sanofi Partners With Dren Bio to Advance Autoimmune Disease Therapies
16 Dec 2025
by Mir Moomin
Read More →
Insilico Medicine Expands AI Platform to Accelerate Drug Discovery
12 Dec 2025
by Mir Moomin
Read More →
Roche Drug Delivers 30% Drop in Breast Cancer Recurrence, Strengthening SERD Pipeline
11 Dec 2025
by Mir Moomin
Read More →
How Texas’s $4 Billion Bet on Cancer Research Signals New Opportunities for Biotech
10 Dec 2025
by Mir Moomin
Read More →
China’s Sichuan Kelun-Biotech Licenses Experimental Cancer Drug to U.S. Firm Crescent Biopharma
8 Dec 2025
by Mir Moomin
Read More →
Lupin Supercharges U.S. Biosimilar Expansion with Armlupeg Licensing to Valorum Biologics
5 Dec 2025
by Rakeeb Amin
Read More →
Regeneron Enters $275M Gene Editing Alliance With Tessera Therapeutics
3 Dec 2025
by Mir Moomin
Read More →
Unlocking the Future of Medicine: The Power of Cell and Gene Therapy
3 Dec 2025
by Mir Moomin
Read More →
Quantum Meets Biotech: IonQ and CCRM Form Global Alliance to Speed Advanced Therapy Development
2 Dec 2025
by Mir Moomin
Read More →
New Research Identifies NSD2 as a Key Driver of Resistance in Advanced Prostate Cancer, Blocking It May Restore Therapy Response
28 Nov 2025
by Rakeeb Amin
Read More →
Novartis Secures FDA Approval In USA For Itvisma, Expanding Access To Gene Therapy For Children, Teens, & Adults With SMA
26 Nov 2025
by Mir Moomin
Read More →
The New Era of Medicine: Treatments That Correct Disease at Its Source
25 Nov 2025
by Mir Moomin
Read More →
Eli Lilly Becomes First Drugmaker to Hit $1 Trillion as Weight-Loss Boom Reshapes Pharma
24 Nov 2025
by Mir Moomin
Read More →
Future BioTech Expo 2026 Announces Launch of Global Biotechnology Forum in Houston
20 Nov 2025
by Urwa A. Beigh
Read More →